Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 814 of 6351
-
Blood concentrate injection may offer new hope for jaw joint pain
Disease control CompletedThis study evaluated the efficacy of injectable platelet-rich fibrin both clinically and using MRI in management of temporomandibular joint internal derangement
Phase 3 • Sponsor: Suez Canal University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Sound waves to the liver: a new weapon against diabetes?
Disease control Recruiting nowThis study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).
Sponsor: Yale University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a pill replace chemo for some breast cancers?
Disease control Recruiting nowThis study is a multi-center, randomized, prospective phase II clinical trial aimed at exploring and evaluating the efficacy of dalpiciclib combined with AI in neoadjuvant treatment for ER strong positive(ER≥50%),HER2-negative, Ki-67≤20%,T1-3N1M0 postmenopausal breast cancer. The…
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Tailored therapy may save colons in severe ulcerative colitis
Disease control Recruiting nowThe goal of this trial is to create personalized treatments for each patient admitted to the hospital with acute severe ulcerative colitis (ASUC). The study will test the feasibility and acceptability of these treatment strategies among patients and physicians so that the study t…
Phase 4 • Sponsor: Berinstein, Jeffrey • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Stem cells offer new hope for stubborn eye ulcers
Disease control Recruiting nowThe proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of allogeneic bone marrow-derived MSCs in patients with nonhealing epitheliopathy …
Phase 2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Simple blood test could decide best therapy for advanced lung cancer
Disease control Recruiting nowThis clinical trial plans to assess to what extent the on-treatment circulating tumor DNA (ctDNA) can predict the subset of patients with NSCLC who will respond to immunotherapy treatment only and which patients will need both immunotherapy and chemotherapy modalities for their t…
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Botox-Like shots could cut migraine days in half
Prevention OngoingThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic migraine. A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head, and is o…
Phase 3 • Sponsor: Ipsen • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
New heart valve study aims to improve treatment for aortic stenosis
Disease control Recruiting nowEvaluation of the safety and performance of the Navitor TAVI System in a Global Study
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a Two-Drug combo outsmart resistant breast cancer?
Disease control Recruiting nowBreast cancer is not only the leading cause of cancer in women, but also the leading cause of cancer deaths in women. Estrogen receptor-positive and HER2-negative breast cancer is the most prevalent breast cancer subtype. Endocrine therapy is the mainstay of treatment; however, d…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can two natural supplements boost antidepressants?
Disease control Recruiting nowThis is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g daily, vs double…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo aims to slow advanced prostate cancer
Disease control CompletedThe purpose of this study is to determine whether the amount of time before disease progression can be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to the standard of care (SOC) of docetaxel and predni…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New vaccine combo shows promise in ovarian cancer fight
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vaccine (FRalphaDC) with pembrolizumab in treating patients with ovarian, fallopian tube, or primary peritoneal cancer (collectively kno…
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Turning stroke recovery into a game: can a knob controller restore hand dexterity?
Disease control Recruiting nowThis study aims at comparing manual function outcomes between the standard of care and additional self-administered hand therapy after stroke. Strokes are common neurological injuries, and although rates of survival have increased in recent decades, survivors often continue to ex…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo drug CagriSema shows promise for diabetes and weight loss
Disease control CompletedThe study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two medicines called semaglutide and cagrilintide. CagriSema will be compared to the two medicines semaglutide and cagrilintide, when t…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Hope for lymphoma patients: new drug cocktail targets resistant cancer
Disease control Recruiting nowThis phase 2 trial studies the side effects and best dose of tazemetostat and zanubrutinib in combination with tafasitamab and lenalidomide, and to see how well these combinations work in treating patients with large B-cell lymphoma that returned or did not respond to earlier tre…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug cocktail aims to control aggressive lung cancer
Disease control Recruiting nowThis study has 2 cohorts: MOZART-ES cohort (for extensive-stage SCLC) and MOZART-LS cohort (for limited-stage SCLC). MOZART-ES cohort: Study treatment will consist of a platinum drug (carboplatin or cisplatin per investigator's choice) plus etoposide plus durvalumab plus monaliz…
Phase 2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a vaccine teach the immune system to fight hepatitis b?
Disease control CompletedThis Phase 1b clinical study is a multi-center, open-label, dose escalation, prime only, and prime plus boost therapeutic vaccination study of 2 distinct chimpanzee adenoviral vectors (AdC6 and AdC7), containing parts of hepatitis B virus (HBV) core and polymerase antigens fused …
Phase 1 • Sponsor: Virion Therapeutics • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Nerve zapper may offer relief for MS-related bladder, bowel, and sexual issues — trial puts it to the test
Symptom relief Recruiting nowA multi-center double-blinded placebo-controlled randomized clinical trial. The patients will be randomized into two groups. To investigate the efficacy of SNM to improve the key bladder diary variables compared to placebo (i.e. sham) for patients with MS having refractory neur…
Sponsor: Odense University Hospital • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a pill tame stubborn hand eczema?
Disease control CompletedThis study is a multicentre, double-blinded, randomized, placebo-controlled, clinical trial with open-label extension. The purpose and aim of this study is to investigate the efficacy and safety of roflumilast (PDE4-inhibitor) in adult patients with chronic hand eczema (CHE). P…
Phase 4 • Sponsor: Jacob Pontoppidan Thyssen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug duo aims to outsmart advanced kidney cancer
Disease control PausedThis study is a randomized, open label, multicenter Phase II trial to evaluate the efficacy and safety of botensilimab (a novel Fc enhanced Tree depleting anti-CTLA4) and balstilimab (a novel anti-PD1) relative to ipilimumab and nivolumab in treatment naïve patients with metastat…
Phase 2 • Sponsor: Michael B. Atkins, MD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC